HomeKNE • CVE
add
Kane Biotech Inc
Previous close
$0.10
Day range
$0.095 - $0.10
Year range
$0.070 - $0.17
Market cap
12.53M CAD
Avg Volume
98.02K
P/E ratio
2.14
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 1.28M | 4,650.21% |
Operating expense | 1.17M | 17.62% |
Net income | -605.81K | 56.05% |
Net profit margin | -47.23 | 99.07% |
Earnings per share | — | — |
EBITDA | -564.91K | 38.02% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 544.38K | -66.46% |
Total assets | 3.91M | -35.03% |
Total liabilities | 4.59M | -64.73% |
Total equity | -688.65K | — |
Shares outstanding | 137.51M | — |
Price to book | -10.00 | — |
Return on assets | -38.31% | — |
Return on capital | -93.34% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -605.81K | 56.05% |
Cash from operations | -538.12K | 24.77% |
Cash from investing | -8.46K | 74.20% |
Cash from financing | 81.03K | -93.39% |
Net change in cash | -465.55K | -197.59% |
Free cash flow | -676.93K | -100.55% |
About
Founded
2001
Headquarters
Website
